共 251 条
[1]
Staatz CE(2004)Clinical pharmacokinetics and pharmacodynamics of tacrolimus in solid organ transplantation Clin Pharmacokinet 43 623-653
[2]
Tett SE(1995)Clinical pharmacokinetics of tacrolimus Clin Pharmacokinet 29 404-430
[3]
Venkataramanan R(2007)CYP3A5 and CYP3A4 but not MDR1 single-nucleotide polymorphisms determine long-term tacrolimus disposition and drug-related nephrotoxicity in renal recipients Clin Pharmacol Ther 82 711-725
[4]
Swaminathan A(2001)The genetic determinants of the CYP3A5 polymorphism Pharmacogenetics 11 773-779
[5]
Prasad T(2001)Sequence diversity in CYP3A promoters and characterization of the genetic basis of polymorphic CYP3A5 expression Nat Genet 27 383-391
[6]
Jain A(2005)CYP3A5 genetic polymorphisms in different ethnic populations Drug Metab Dispos 33 884-887
[7]
Zuckerman S(2013)Impact of CYP3A5 genotype on tacrolimus versus midazolam clearance in renal transplant recipients: new insights in CYP3A5-mediated drug metabolism Pharmacogenomics 14 1467-1480
[8]
Warty V(2009)A population pharmacokinetic model of ciclosporin applicable for assisting dose management of kidney transplant recipients Clin Pharmacokinet 48 615-623
[9]
McMichael J(2013)Personalized tacrolimus doses determined by CYP3A5 genotype for induction and maintenance phases of kidney transplantation Clin Ther 35 1762-1769
[10]
Lever J(2013)Inclusion of CYP3A5 genotyping in a nonparametric population model improves dosing of tacrolimus early after transplantation Transpl Int 95 821-827